Ginkgo Bioworks Holdings (DNA) Capital Leases (2020 - 2022)

Ginkgo Bioworks Holdings' Capital Leases history runs 3 years deep, the most recent figure standing at $59.8 million for Q3 2022.

• Quarterly Capital Leases rose 267.85% year-over-year to $59.8 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $59.8 million (up 267.85% YoY) and the FY2021 annual result came in at $22.3 million, up 34.9% from the prior year.
• Capital Leases was $59.8 million for Q3 2022 at Ginkgo Bioworks Holdings, up from $51.5 million in the prior quarter.
• Across five years, Capital Leases topped out at $59.8 million in Q3 2022 and bottomed at $16.3 million in Q3 2021.
• A 3-year average of $32.3 million and a median of $24.8 million in 2021 frame the typical range for Capital Leases.
• Annual changes were most pronounced in 2021 — Capital Leases soared 34.9% — and 2022, when it jumped 267.85%.
• Ginkgo Bioworks Holdings' Capital Leases stood at $16.5 million in 2020, then jumped by 34.9% to $22.3 million in 2021, then jumped by 168.55% to $59.8 million in 2022.
• Business Quant data shows DNA's Capital Leases at $59.8 million in Q3 2022, $51.5 million in Q2 2022, and $27.3 million in Q1 2022.